Tuesday, June 2, 2026

MCOs with LTSS contracts face potential workforce disruption if home care aides lose Medicaid coverage due to work hour documentation requirements, threatening network adequacy and care continuity for members receiving home-based services.

Significant ASP-AMP spreads can trigger Medicaid rebate adjustments and affect managed care pharmacy costs, particularly for specialty drugs and physician-administered medications covered under both Medicare Part B and Medicaid managed care carve-ins.

Medicaid managed care organizations contracting with 340B hospitals may face increased pharmacy costs if facilities lose discount eligibility and shift more expensive claims to health plans or seek higher reimbursement rates to offset lost savings.

Medicaid managed care organizations contract with 340B hospitals whose financial stability and pharmacy operations could be disrupted if Lilly follows through, potentially affecting network adequacy and access to pharmaceutical services for Medicaid beneficiaries.

Medicaid managed care organizations processing pharmacy claims need to track whether providers are billing for drugs already purchased at 340B discounts, as duplicate payments trigger rebate violations and federal compliance issues.

MCOs will face new operational burdens tracking member work status, coordinating exemption documentation with state eligibility systems, and managing disenrollment processes for non-compliant beneficiaries, with direct impacts on enrollment forecasts, capitation revenue, and care management workflows.

Medicaid MCOs will need to modify systems for beneficiary reporting, coordinate with state agencies on exemption verification, adjust enrollment forecasting models, and prepare for potential coverage disruptions affecting care management and risk adjustment.

Large-scale Medicaid disenrollment in New Jersey would trigger significant membership loss for managed care organizations, reduce capitation revenue, and shift care delivery patterns toward higher-cost emergency department settings as uninsured patients delay preventive and primary care.

Large-scale Medicaid disenrollment in New Jersey will shift uncompensated care costs to providers and may trigger MCO enrollment declines, capitation adjustments, and increased emergency utilization.

Demonstrates measurable ROI for medically tailored meals as a potential value-based care intervention or supplemental benefit under managed care contracts, particularly for members with diabetes, cardiovascular disease, and other nutrition-related chronic conditions.

Oregon's results provide evidence for MCOs evaluating food-as-medicine programs under in-lieu-of services or value-based arrangements targeting high-cost, high-need populations.

Medicaid managed care organizations with behavioral health carve-ins or contracted psychiatric hospital networks in California must ensure network providers comply with the new staffing ratios to avoid access disruptions, potential state enforcement actions against contracted facilities, and adequacy deficiencies.

MCOs with behavioral health networks in California face immediate compliance obligations to verify contracted psychiatric facilities meet new state-mandated staffing ratios, with potential network adequacy and quality performance implications if providers cannot comply.

Medicaid MCOs that contract with telehealth vendors for behavioral health, substance use disorder treatment, or primary care services may face network disruption if those vendors are forced to restructure or cease operations in affected states.

Medicaid MCOs relying on telehealth vendors for behavioral health, primary care, or specialty services may face network disruptions if state enforcement forces platform restructuring or exit from certain markets.

This lawsuit demonstrates that state attorneys general are actively pursuing Medicaid managed care organizations for alleged risk adjustment gaming, creating significant financial and compliance exposure for plans that fail to maintain defensible diagnosis coding and risk score documentation practices.

The case signals intensified state enforcement of risk adjustment integrity and could prompt audits of MCO diagnosis coding practices in other states where capitation rates are tied to member acuity scores.

Medicaid MCOs must immediately review member materials, utilization management protocols, and staff training to ensure compliance with the narrowed federal nondiscrimination standard while monitoring for appeals or conflicting guidance from CMS.

Medicaid MCOs must immediately review and potentially revise policies, coverage criteria, and training materials that rely on the now-vacated gender identity protections under Section 1557.

Medicaid MCOs with operations in Arizona, Nevada, or California face heightened fraud enforcement risk and should review compliance programs, provider network oversight, and claims integrity processes in anticipation of coordinated federal investigations.

MCOs in Arizona, Nevada, and California face increased federal enforcement risk and should review their fraud, waste, and abuse detection programs and provider oversight mechanisms to ensure compliance with federal False Claims Act standards.

Medicaid managed care organizations could face pharmacy cost increases if 340B hospital access to discounted drugs is restricted, potentially affecting drug rebate calculations and contract pharmacy arrangements with safety-net providers.

Medicaid managed care organizations operating in rural areas face network adequacy requirements and emergency service access obligations even when local hospitals close, creating care coordination challenges and potentially higher costs for member transportation and out-of-area utilization.

The exclusion of hospital reopening costs from federal rural health funding means Medicaid MCOs in underserved areas will continue managing members with limited acute care access and higher emergency transportation costs.